Seegnal eHealth releases Seegnal 9.0, Delivering a New Standard of Care

Seegnal 9.0 offers groundbreaking clinical insights combined with technological maturity

August 24^th, 2020, Tel Aviv – Seegnal eHealth Ltd. is reinventing patient care with its revolutionary, patient-specific digital platform that enables preventing Drug Related Problems (DRPs) at the point-of-care. Today, the company released Version 9.0 of its unique platform, powering cutting- edge capabilities second to none in the healthcare industry.

Leveraging on its smart, patient-adaptive algorithms, Seegnal eHealth has taken a significant leap forward to offer unique capabilities, including:

• Clinical capabilities to improve both patient care and ease of use
  • Optimizing QT prolongation alerts – utilizing proprietary algorithms to consider all relevant patient modifiers
  • Enhanced pharmacogenetics module based on latest FDA recommendations
  • Mechanism-based inference DRPs
• Seegnal as a platform – Technical upgrades and improvements
  • Modernized infrastructure and architecture to significantly improve performance, flexibility, and ease of deployment
  • Platform capabilities – Seamless integration of data received from auxiliary systems
  • Improved GUI and usability
  • Developed all required FHIR interoperability
  • Utilizing the newly introduced CDS Hooks standard 

“We are excited to release Seegnal 9.0, enabling us to best serve our customers and their patients. We believe that this comprehensive platform is setting a new standard in Clinical Decision Support platforms. Seegnal 9.0 delivers unparalleled clinical depth and expertise, combined with technical superiority and ease of use, at the point of care,” said Roni Shiloh, MD, Seegnal’s CEO and Founder. “This version will be installed with new customers, as well as used for upgrading previous versions already in use. Going forward, we will continue to develop innovative modules, which will further enhance patient specificity and improve overall medication therapy standards”.

About Seegnal
Seegnal eHealth Ltd. was established with the goal of globally disrupting the clinician-medication-patient value chain by
Introducing revolutionary concepts, new knowledge, and advanced technologies, generating both value and safety. Seegnal is a smart and intuitive clinical decision support platform that empowers clinicians to quickly and effectively manage and resolve patient-specific Drug-Related Problems (DRPs, the 4^th leading cause of death in the US alone). Seegnal interfaces with the EMR at the point of care, and harnesses the widest scope of DRP-related information, generating an additional 50% of unique data (which legacy systems either don’t recognize or address), while delivering ground-breaking accuracy (sensitivity and specificity) of about 95%. The platform diminishes alert fatigue (about 6% alert load vs. legacy systems), and is intuitive and easy to use, requiring only 5-10 seconds for DRP detection, prioritization, and resolution. For additional information, please contact limor.rubinstein@seegnal.com.